PRMT7: a survive-or-die switch in cancer stem cells
Crossref DOI link: https://doi.org/10.1186/s12943-022-01602-z
Published Online: 2022-06-10
Published Print: 2022-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nicot, Christophe
Text and Data Mining valid from 2022-06-10
Version of Record valid from 2022-06-10
Article History
First Online: 10 June 2022
Declarations
:
: The author declares no financial conflict of interest. Christophe Nicot is Editor-in-Chief of Molecular Cancer.